News | November 01, 2024
Supriya Lifescience reports 19% revenue increase in Q2 FY25
The company reported a net profit of Rs 46.15 crore in Q2 FY25 as compared to Rs 23.88 crore in Q2 FY24
The company reported a net profit of Rs 46.15 crore in Q2 FY25 as compared to Rs 23.88 crore in Q2 FY24
Silica is a proven and highly effective anti-caking agent that has been used for decades
ActivShield technology is a portable, novel sterilization modality that does not require conventional infrastructure
The proceeds from its fresh issuance to the extent of Rs 107 crore will be utilized for funding the capital expenditure requirements
Fludrocortisone acetate tablets will be produced at the Group's manufacturing site at Moraiya, Ahmedabad
The share subscription agreements are being executed at a pre-money equity value of US$ 1.65 billion
GBM affects nearly 13,000 patients annually in the US and approximately 300,000 globally
Paliperidone extended-release tablets will be produced at the Group’s manufacturing site at SEZ, Ahmedabad
Clarity in regulatory frameworks and pathways help in preventing delays in accessing quality-assured, affordable medicines
WEF recognises company’s Bharuch manufacturing facility as a global manufacturing lighthouse
Subscribe To Our Newsletter & Stay Updated
